We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNI
501
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $14.9M | 0.03% |
190,233
+6,038
| +3% | +$467K |
|
502
W.R. Berkley
WRB
$28.1B
| $14.9M | 0.03% |
711,777
+122,785
| +21% | +$2.53M |
|
503
Cognex
CGNX
$9.62B
| $14.9M | 0.03% |
353,838
+10,010
| +3% | +$366K |
|
504
IQVIA
IQV
$40.7B
| $14.8M | 0.03% |
183,569
+14,608
| +9% | +$1.14M |
|
505
Omega Healthcare
OHI
$15.3B
| $14.8M | 0.03% |
447,159
+33,585
| +8% | +$1.08M |
|
|
FLG
506
Flagstar Bank National Association
FLG
$5.87B
| $14.7M | 0.03% |
351,580
+9,873
| +3% | +$445K |
|
507
Cboe Global Markets
CBOE
$32.2B
| $14.7M | 0.03% |
180,994
+2,635
| +1% | +$206K |
|
508
NNN REIT
NNN
$9.29B
| $14.7M | 0.03% |
336,195
+26,724
| +9% | +$1.18M |
|
|
HBI
509
DELISTED
Hanesbrands
HBI
| $14.6M | 0.03% |
704,756
+21,817
| +3% | +$463K |
|
510
Kilroy Realty
KRC
$4.59B
| $14.5M | 0.03% |
201,274
+21,234
| +12% | +$1.57M |
|
511
Zions Bancorporation
ZION
$10.1B
| $14.5M | 0.03% |
344,706
+16,982
| +5% | +$738K |
|
512
NiSource
NI
$21.5B
| $14.4M | 0.03% |
606,940
+23,408
| +4% | +$536K |
|
513
Helmerich & Payne
HP
$3.34B
| $14.4M | 0.03% |
216,874
+37,466
| +21% | +$2.67M |
|
514
Chemours
CC
$2.48B
| $14.4M | 0.03% |
374,630
+111,221
| +42% | +$3.35M |
|
515
Pediatrix Medical
MD
$2.2B
| $14.4M | 0.03% |
207,382
+14,353
| +7% | +$997K |
|
|
BEAV
516
DELISTED
B/E Aerospace Inc
BEAV
| $14.4M | 0.03% |
224,422
+6,720
| +3% | +$421K |
|
517
SEI Investments
SEIC
$12.3B
| $14.3M | 0.03% |
284,134
-11,912
| -4% | -$601K |
|
518
Perrigo
PRGO
$1.44B
| $14.3M | 0.03% |
215,803
+11,206
| +5% | +$852K |
|
519
Hubbell
HUBB
$24.4B
| $14.3M | 0.03% |
119,269
+8,435
| +8% | +$1.01M |
|
520
Lamar Advertising Co
LAMR
$16.7B
| $14.2M | 0.03% |
190,178
+11,448
| +6% | +$859K |
|
521
OGE Energy
OGE
$9.87B
| $14.1M | 0.03% |
403,832
+9,143
| +2% | +$318K |
|
522
Avery Dennison
AVY
$12.8B
| $14.1M | 0.03% |
175,175
+4,162
| +2% | +$323K |
|
523
Dell
DELL
$239B
| $14.1M | 0.03% |
784,326
+34,339
| +5% | +$599K |
|
524
American Financial Group
AFG
$11.9B
| $14.1M | 0.03% |
147,503
-1,704
| -1% | -$156K |
|
525
MGM Resorts International
MGM
$11.7B
| $14.1M | 0.03% |
513,371
+25,498
| +5% | +$707K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.